Compositions of an orally active 1,2,4oxadiazole for nonsense mutation suppression therapy

Details for Australian Patent Application No. 2006235115 (hide)

Owner PTC Therapeutics, Inc.

Inventors Hirawat, Samit; Miller, Langdon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006235115

PCT Pub. Number WO2006/110483

Priority 60/669,789 08.04.05 US; 60/787,395 30.03.06 US

Filing date 6 April 2006

Wipo publication date 19 October 2006

Acceptance publication date 5 July 2012

International Classifications

A61K 31/4245 - Oxadiazoles

A61P 3/10 Drugs for disorders of the metabolism

A61P 7/00 Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 11/00 Drugs for disorders of the respiratory system

A61P 25/00 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

A61P 35/00 Antineoplastic agents

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/110483 Priority application(s): WO2006/110483

5 July 2012 Application Accepted

  Published as AU-B-2006235115

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235123-Complementary compositions to reduce blood glucose levels and treat diabetes

2006235114-Borate-polyol mixtures as a buffering system